Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Corticotroph aggressive pituitary tumours and carcinomas frequently harbour ATRX mutations

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Modified-release Hydrocortisone in Congenital Adrenal Hyperplasia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Total and central adiposity are associated with age at gonadarche and incidence of precocious gonadarche in boys

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The calcium-sensing receptor is essential for calcium and bicarbonate sensitivity in human spermatozoa

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Establishment of a novel human fetal adrenal culture model that supports de novo and manipulated steroidogenesis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Incidence and Clinical Presentation of Pheochromocytoma and Sympathetic Paraganglioma: A Population-based Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Multiple endocrine neoplasia type 1 (MEN-1) and neuroendocrine neoplasms (NENs)

    Publikation: Bidrag til tidsskriftReviewpeer review

  2. Identification of human glucocorticoid response markers using integrated multi-omic analysis from a randomized crossover trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Multiple endocrine neoplasia type 2: A reveiw

    Publikation: Bidrag til tidsskriftReviewpeer review

  • Olivera Casar-Borota
  • Henning Bünsow Boldt
  • Britt Edén Engström
  • Marianne Skovsager Andersen
  • Bertrand Baussart
  • Daniel Bengtsson
  • Katarina Berinder
  • Bertil Ekman
  • Ulla Feldt-Rasmussen
  • Charlotte Höybye
  • Jens Otto L Jørgensen
  • Anders Jensen Kolnes
  • Márta Korbonits
  • Åse Krogh Rasmussen
  • John R Lindsay
  • Paul Benjamin Loughrey
  • Dominique Maiter
  • Emilija Manojlovic-Gacic
  • Jens Pahnke
  • Pietro Luigi Poliani
  • Vera Popovic
  • Oskar Ragnarsson
  • Camilla Schalin-Jäntti
  • David Scheie
  • Miklós Tóth
  • Chiara Villa
  • Martin Wirenfeldt
  • Jacek Kunicki
  • Pia Burman
Vis graf over relationer

CONTEXT: Aggressive pituitary tumours (APTs) are characterised by unusually rapid growth and lack of response to standard treatment. About 1-2% develop metastases being classified as pituitary carcinomas (PCs). For unknown reasons, the corticotroph tumours are overrepresented amongst APTs and PCs. Mutations in the ATRX gene, regulating chromatin remodelling and telomere maintenance, have been implicated in the development of several cancer types, including neuroendocrine tumours.

OBJECTIVE: To study ATRX protein expression and mutational status of the ATRX gene in APTs and PCs.

DESIGN: We investigated ATRX protein expression by using immunohistochemistry in 30 APTs and 18 PCs, mostly of Pit-1 and T-Pit cell lineage. In tumours lacking ATRX immunolabeling, mutational status of the ATRX gene was explored.

RESULTS: Nine of the 48 tumours (19%) demonstrated lack of ATRX immunolabelling with a higher proportion in patients with PCs (5/18 - 28%) than in those with APTs (4/30 - 13%). Lack of ATRX was most common in the corticotroph tumours, 7/22 (32%), vs 2/24 (8%) in the tumours of the Pit-1 lineage. Loss-of-function ATRX mutations were found in all the nine ATRX immuno-negative cases: nonsense mutations (n=4), frameshift deletions (n=4) and large deletions affecting 22-28 of the 36 exons (n=3). More than one ATRX gene defect was identified in two PCs.

CONCLUSION: ATRX mutations occur in a subset of aggressive pituitary tumours and are more common in corticotroph tumours. The findings provide a rationale for performing ATRX immunohistochemistry to identify patients at risk of developing aggressive and potentially metastatic pituitary tumours.

OriginalsprogEngelsk
TidsskriftThe Journal of clinical endocrinology and metabolism
ISSN0021-972X
DOI
StatusUdgivet - 26 okt. 2020

Bibliografisk note

© The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society.

ID: 61434695